138 related articles for article (PubMed ID: 2850958)
1. Binding sites for peptide-histidine-isoleucine (PHI) on rat insulinoma-derived RINm5F cells.
Göke R; Conlon JM
Mol Cell Endocrinol; 1988 Dec; 60(2-3):211-5. PubMed ID: 2850958
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells.
Andersson M; Sillard R; Rökaeus A
Regul Pept; 1992 Jul; 40(1):41-9. PubMed ID: 1332138
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
5. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
6. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.
Göke R; Conlon JM
J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504
[TBL] [Abstract][Full Text] [Related]
7. Distribution of somatostatin receptors in RINm5F insulinoma cells.
Sullivan SJ; Schonbrunn A
Endocrinology; 1988 Mar; 122(3):1137-45. PubMed ID: 2893729
[TBL] [Abstract][Full Text] [Related]
8. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP formation in chicken brain: effect of vasoactive intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides.
Dejda A; Matczak I; Wiktorowska-Owczarek A; Nowak JZ
Pol J Pharmacol; 2003; 55(5):747-51. PubMed ID: 14704471
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the interaction of the glucagon receptor, cAMP, and insulin secretion in parent cells and clone 5F of a cultured rat insulinoma.
Korman LY; Bhathena SJ; Voyles NR; Oie HK; Recant L
Diabetes; 1985 Aug; 34(8):717-22. PubMed ID: 2991048
[TBL] [Abstract][Full Text] [Related]
13. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
Calvo JR; Guerrero JM; Goberna R
Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
[TBL] [Abstract][Full Text] [Related]
14. High affinity peptide histidine isoleucine-preferring receptors in rat liver.
Paul S; Chou J; Kubota E
Life Sci; 1987 Nov; 41(21):2373-80. PubMed ID: 2824950
[TBL] [Abstract][Full Text] [Related]
15. A peptide histidine isoleucine/peptide histidine methionine-like peptide in the rabbit retina: colocalization with vasoactive intestinal peptide, synaptic relationships and activation of adenylate cyclase activity.
Pachter JA; Marshak DW; Lam DM; Fry KR
Neuroscience; 1989; 31(2):507-19. PubMed ID: 2797447
[TBL] [Abstract][Full Text] [Related]
16. Characterization of somatostatin receptors which mediate inhibition of insulin secretion in RINm5F insulinoma cells.
Sullivan SJ; Schonbrunn A
Endocrinology; 1987 Aug; 121(2):544-52. PubMed ID: 2885182
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
18. Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cells.
Göke R; Richter G; Göke B; Trautmann M; Arnold R
Res Exp Med (Berl); 1989; 189(4):257-64. PubMed ID: 2554438
[TBL] [Abstract][Full Text] [Related]
19. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
